Immutep's Efti in Combination with KEYTRUDA ® (pembrolizumab) Drives Strong Overall Survival in Head and Neck Cancer with CPS
4 hours ago
2
-
Homepage
-
Finance
- Immutep's Efti in Combination with KEYTRUDA ® (pembrolizumab) Drives Strong Overall Survival in Head and Neck Cancer with CPS